Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4155432)

Published in J Natl Cancer Inst on July 30, 2014

Authors

Sharon M Castellino1, Nicole J Ullrich2, Megan J Whelen2, Beverly J Lange2

Author Affiliations

1: Department of Pediatrics, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC (SMC); Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC (SMC, MJW); Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA (NJU); Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, Philadelphia, PA (BJL). scastell@wakehealth.edu.
2: Department of Pediatrics, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC (SMC); Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC (SMC, MJW); Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA (NJU); Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, Philadelphia, PA (BJL).

Associated clinical trials:

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors | NCT00369785

Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain | NCT00452868

Neuropsychological and Behavioral Testing in Younger Patients With Cancer | NCT00772200

Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor | NCT01381718

Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy | NCT01503086

The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 (MP-COVID) | NCT04632719

Articles cited by this

(truncated to the top 100)

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med (2005) 5.81

Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA (2003) 5.27

Cerebellum and nonmotor function. Annu Rev Neurosci (2009) 4.80

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med (1993) 4.28

Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol (2004) 3.56

Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst (2009) 3.52

Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil (2005) 3.51

Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.04

Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol (2012) 3.01

Functional plasticity or vulnerability after early brain injury? Pediatrics (2005) 2.87

Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury. AJNR Am J Neuroradiol (2004) 2.78

Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2006) 2.71

Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol (2003) 2.50

Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol (2009) 2.34

Glioma cells release excitotoxic concentrations of glutamate. Cancer Res (1999) 2.34

Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol (2012) 2.33

Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep (2007) 2.31

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol (2001) 2.30

Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology (2009) 2.29

Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol (2005) 2.26

Social outcomes in the Childhood Cancer Survivor Study cohort. J Clin Oncol (2009) 2.25

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol (2005) 2.24

Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol (2004) 2.24

Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet (1981) 2.21

Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol (2006) 2.19

Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17

Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol (2009) 2.17

Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study. J Clin Oncol (2004) 2.15

Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol (2008) 2.14

Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer (2003) 2.11

Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer (2003) 2.10

Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol (2009) 1.96

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. J Clin Oncol (1998) 1.94

The development of nonverbal working memory and executive control processes in adolescents. Child Dev (2005) 1.93

Short- and long-term social outcomes following pediatric traumatic brain injury. J Int Neuropsychol Soc (2004) 1.92

Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia. Blood (2008) 1.89

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry (2011) 1.89

Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer (2003) 1.88

Structural plasticity upon learning: regulation and functions. Nat Rev Neurosci (2012) 1.88

Radiation injury and neurogenesis. Curr Opin Neurol (2003) 1.86

Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. J Natl Cancer Inst (2010) 1.83

Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol (2000) 1.81

X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience (2000) 1.80

Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology (2000) 1.76

Diffusion tensor tractography of traumatic diffuse axonal injury. Arch Neurol (2008) 1.76

A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol (2008) 1.75

Childhood cancer epidemiology in low-income countries. Cancer (2008) 1.74

A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer (2007) 1.73

Posttraumatic stress, family functioning, and social support in survivors of childhood leukemia and their mothers and fathers. J Consult Clin Psychol (1997) 1.72

Long-term health status among survivors of childhood cancer: does sex matter? J Clin Oncol (2007) 1.72

Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol (2005) 1.71

Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol (2007) 1.69

Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev (2009) 1.69

Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil (2004) 1.68

Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab (2012) 1.67

A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer (2008) 1.66

Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol (2006) 1.66

Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer (2006) 1.64

How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil (2011) 1.64

Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med (2007) 1.62

Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer (2005) 1.57

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics (2005) 1.57

Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors. Pediatr Blood Cancer (2010) 1.57

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Pediatr Blood Cancer (2008) 1.55

Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer (2011) 1.55

Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Brain Res Mol Brain Res (1999) 1.53

Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics (2010) 1.52

Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev (2006) 1.52

CNS complications of radiotherapy and chemotherapy. Lancet (2009) 1.51

Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist (2004) 1.49

Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol (2009) 1.49

Ecological assessment of executive function in traumatic brain injury. Dev Neuropsychol (2004) 1.48

Educational and occupational outcomes among survivors of childhood cancer during the transition to emerging adulthood. J Dev Behav Pediatr (2007) 1.47

Feasibility and preliminary outcomes from a pilot study of a brief psychological intervention for families of children newly diagnosed with cancer. J Pediatr Psychol (2005) 1.45

Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol (2005) 1.44

Diffusion tensor imaging in relation to cognitive and functional outcome of traumatic brain injury in children. J Head Trauma Rehabil (2008) 1.42

Inhibition of dentate granule cell neurogenesis with brain irradiation does not prevent seizure-induced mossy fiber synaptic reorganization in the rat. J Neurosci (1999) 1.42

Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol (2007) 1.42

The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Horm IGF Res (2005) 1.42

Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst (2012) 1.41

Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol (2008) 1.40

Moyamoya following cranial irradiation for primary brain tumors in children. Neurology (2007) 1.40

In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS Med (2008) 1.37

Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol (2008) 1.37

Mechanisms of radiation-induced brain toxicity and implications for future clinical trials. J Neurooncol (2008) 1.33

Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol (2007) 1.31

Spatial learning and memory deficits after whole-brain irradiation are associated with changes in NMDA receptor subunits in the hippocampus. Radiat Res (2006) 1.31

Unemployment among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Med Care (2010) 1.31

Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging (2000) 1.31

White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys (2008) 1.30

Development of six PROMIS pediatrics proxy-report item banks. Health Qual Life Outcomes (2012) 1.29

Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr (2007) 1.29

Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol (2001) 1.29

Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130). J Clin Oncol (2005) 1.28

Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol (2005) 1.28

Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol (2007) 1.27

Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer (2009) 1.27

Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc (2002) 1.27

Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies. Neuro Oncol (2010) 1.27

Does age really matter? Recall of information presented to newly referred patients with cancer. J Clin Oncol (2008) 1.25